MA54626A - Complexe de gadolinium et d'un ligand chelateur derive de pcta diastereoisomeriquement enrichi et procede de preparation et de purification - Google Patents

Complexe de gadolinium et d'un ligand chelateur derive de pcta diastereoisomeriquement enrichi et procede de preparation et de purification

Info

Publication number
MA54626A
MA54626A MA054626A MA54626A MA54626A MA 54626 A MA54626 A MA 54626A MA 054626 A MA054626 A MA 054626A MA 54626 A MA54626 A MA 54626A MA 54626 A MA54626 A MA 54626A
Authority
MA
Morocco
Prior art keywords
pcta
gadolinium
purification
complex
preparation
Prior art date
Application number
MA054626A
Other languages
English (en)
French (fr)
Inventor
Martine Cerf
Alain Chénedé
Bruno François
Greneur Soizic Le
Stéphanie Louguet
Emmanuelle Marais
Myriam Petta
Caroline Robic
Original Assignee
Guerbet Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Guerbet Sa filed Critical Guerbet Sa
Publication of MA54626A publication Critical patent/MA54626A/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/003Compounds containing elements of Groups 3 or 13 of the Periodic Table without C-Metal linkages
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/06Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/06Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10Organic compounds
    • A61K49/101Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals
    • A61K49/106Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals the complex-forming compound being cyclic, e.g. DOTA
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/08Bridged systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Radiology & Medical Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
MA054626A 2019-01-17 2020-01-17 Complexe de gadolinium et d'un ligand chelateur derive de pcta diastereoisomeriquement enrichi et procede de preparation et de purification MA54626A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR1900432A FR3091873B1 (fr) 2019-01-17 2019-01-17 Complexe de gadolinium et d’un ligand chelateur derive de pcta diastereoisomeriquement enrichi et procede de preparation et de purification

Publications (1)

Publication Number Publication Date
MA54626A true MA54626A (fr) 2022-04-20

Family

ID=67001953

Family Applications (2)

Application Number Title Priority Date Filing Date
MA055389A MA55389A (fr) 2019-01-17 2020-01-17 Complexe de gadolinium et d'un ligand chelateur derive de pcta diastereoisomeriquement enrichi et procede de preparation et de purification
MA054626A MA54626A (fr) 2019-01-17 2020-01-17 Complexe de gadolinium et d'un ligand chelateur derive de pcta diastereoisomeriquement enrichi et procede de preparation et de purification

Family Applications Before (1)

Application Number Title Priority Date Filing Date
MA055389A MA55389A (fr) 2019-01-17 2020-01-17 Complexe de gadolinium et d'un ligand chelateur derive de pcta diastereoisomeriquement enrichi et procede de preparation et de purification

Country Status (28)

Country Link
US (3) US11590246B2 (enAn)
EP (2) EP3943493B1 (enAn)
JP (2) JP7071596B2 (enAn)
KR (2) KR102438394B1 (enAn)
CN (3) CN119552163A (enAn)
AR (1) AR117835A1 (enAn)
AU (1) AU2020208794B2 (enAn)
BR (1) BR112021014006B1 (enAn)
CA (1) CA3126268C (enAn)
CL (1) CL2021001868A1 (enAn)
CO (1) CO2021009261A2 (enAn)
DK (2) DK3902800T3 (enAn)
ES (2) ES2950118T3 (enAn)
FI (1) FI3943493T3 (enAn)
FR (1) FR3091873B1 (enAn)
HR (2) HRP20230678T1 (enAn)
HU (2) HUE062554T2 (enAn)
IL (1) IL284884B1 (enAn)
MA (2) MA55389A (enAn)
MX (1) MX2021008651A (enAn)
PH (1) PH12021551725A1 (enAn)
PL (2) PL3943493T3 (enAn)
PT (2) PT3943493T (enAn)
RS (1) RS64334B1 (enAn)
SG (1) SG11202107779SA (enAn)
TW (1) TWI811518B (enAn)
WO (1) WO2020148436A1 (enAn)
ZA (1) ZA202104994B (enAn)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN119039292A (zh) 2018-08-06 2024-11-29 伯拉考成像股份公司 基于带有钆的pcta的造影剂
FR3091873B1 (fr) * 2019-01-17 2020-12-25 Guerbet Sa Complexe de gadolinium et d’un ligand chelateur derive de pcta diastereoisomeriquement enrichi et procede de preparation et de purification
FR3091872B1 (fr) * 2019-01-17 2020-12-25 Guerbet Sa Complexe de gadolinium et d’un ligand chelateur derive de pcta diastereoisomeriquement enrichi et procede de synthese
CN116209661A (zh) * 2020-07-17 2023-06-02 法国加栢 用于制备基于pcta的螯合配体的方法
WO2022072947A1 (en) * 2020-10-02 2022-04-07 Eagle Harbor Technologies, Inc. Ion current droop compensation
WO2024049087A1 (ko) * 2022-09-01 2024-03-07 주식회사 테라노큐어 신규한 화합물 및 이를 포함하는 mri 조영제

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4647447A (en) 1981-07-24 1987-03-03 Schering Aktiengesellschaft Diagnostic media
DE3640708C2 (de) 1986-11-28 1995-05-18 Schering Ag Verbesserte metallhaltige Pharmazeutika
DE4001655A1 (de) 1990-01-18 1991-07-25 Schering Ag 6-ring enthaltende makrocyclische tetraaza-verbindungen, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische mittel
JPH04154729A (ja) 1990-10-16 1992-05-27 Nippon Mejifuijitsukusu Kk 磁気共鳴造影剤
IT1292128B1 (it) 1997-06-11 1999-01-25 Bracco Spa Processo per la preparazione di chelanti macrociclici e loro chelati con ioni metallici paramagnetici
EP0992245A1 (en) 1998-09-16 2000-04-12 Goldham Bioglan Pharma GmbH Radio-contrast agents
FR2793795B1 (fr) * 1999-05-21 2001-08-03 Guerbet Sa Isomeres de tetramides du complexe de gadolinium de l'acide (1,4,7,10-tetrazacyclododecane)1,4,7,10-tetra(2-glutarique) leur procede de preparation et leur application en imagerie medicale
FR2794744B1 (fr) 1999-06-09 2001-09-21 Guerbet Sa Complexes metalliques de polyaminoacides bicycliques, leur procede de preparation et leur application en imagerie medicale
FR2891830B1 (fr) * 2005-10-07 2011-06-24 Guerbet Sa Composes a chaines aminoalcools courtes et complexes metalliques pour l'imagerie medicale
US20090208421A1 (en) * 2008-02-19 2009-08-20 Dominique Meyer Process for preparing a pharmaceutical formulation of contrast agents
US8119817B2 (en) 2009-09-29 2012-02-21 Degussa-Huels Ag Process for separating the diastereomers of RSS-and SSS-N- α [1-carboxy-3-phenylpropyl] lysylproline
EP2786768A1 (en) * 2013-04-04 2014-10-08 Agfa Healthcare Process for preparing a material comprising a macrocyclic ligand and for producing a pharmaceutical formulation comprising said ligand with a lanthanide
JP6608805B2 (ja) * 2013-04-26 2019-11-20 ゲルベ 造影製剤および関連する調製方法
CN104188957B (zh) 2014-05-28 2017-04-26 中国中医科学院西苑医院 一种防治再狭窄的药物及其制备和使用方法
JP6826267B2 (ja) 2017-04-28 2021-02-03 株式会社大塚製薬工場 クエン酸誘導体のジアステレオマーの製造方法
CN119039292A (zh) 2018-08-06 2024-11-29 伯拉考成像股份公司 基于带有钆的pcta的造影剂
FR3091873B1 (fr) 2019-01-17 2020-12-25 Guerbet Sa Complexe de gadolinium et d’un ligand chelateur derive de pcta diastereoisomeriquement enrichi et procede de preparation et de purification
FR3091872B1 (fr) 2019-01-17 2020-12-25 Guerbet Sa Complexe de gadolinium et d’un ligand chelateur derive de pcta diastereoisomeriquement enrichi et procede de synthese

Also Published As

Publication number Publication date
EP3943493A1 (fr) 2022-01-26
US11590246B2 (en) 2023-02-28
TW202043227A (zh) 2020-12-01
DK3902800T3 (da) 2022-11-28
BR112021014006A2 (pt) 2021-09-21
ES2930136T3 (es) 2022-12-07
FI3943493T3 (fi) 2023-07-19
HRP20230678T1 (hr) 2023-09-29
HUE060343T2 (hu) 2023-02-28
US20230149568A1 (en) 2023-05-18
AU2020208794B2 (en) 2023-01-12
RS64334B1 (sr) 2023-08-31
CN113735854A (zh) 2021-12-03
DK3943493T3 (da) 2023-07-24
CN119552163A (zh) 2025-03-04
JP7321230B2 (ja) 2023-08-04
IL284884A (en) 2021-08-31
MA55389A (fr) 2022-01-26
FR3091873B1 (fr) 2020-12-25
JP2022009463A (ja) 2022-01-14
MX2021008651A (es) 2021-10-26
AU2020208794A1 (en) 2021-08-05
CO2021009261A2 (es) 2021-12-10
KR102502862B1 (ko) 2023-02-23
EP3943493B1 (fr) 2023-04-19
CN113735854B (zh) 2024-05-14
CA3126268A1 (fr) 2020-07-23
JP7071596B2 (ja) 2022-05-19
US20240358863A1 (en) 2024-10-31
SG11202107779SA (en) 2021-08-30
KR102438394B1 (ko) 2022-09-01
EP3902800A1 (fr) 2021-11-03
ZA202104994B (en) 2023-04-26
AR117835A1 (es) 2021-08-25
CN113646308A (zh) 2021-11-12
WO2020148436A1 (fr) 2020-07-23
HUE062554T2 (hu) 2023-11-28
FR3091873A1 (fr) 2020-07-24
PH12021551725A1 (en) 2022-04-11
ES2950118T3 (es) 2023-10-05
HRP20221402T1 (hr) 2023-01-06
PL3943493T3 (pl) 2023-08-07
TWI811518B (zh) 2023-08-11
US12064487B2 (en) 2024-08-20
JP2022508496A (ja) 2022-01-19
PT3943493T (pt) 2023-07-12
CA3126268C (fr) 2024-01-09
KR20210109039A (ko) 2021-09-03
CN113646308B (zh) 2024-12-13
BR112021014006B1 (pt) 2023-05-02
US20220062443A1 (en) 2022-03-03
PT3902800T (pt) 2022-11-16
EP3902800B1 (fr) 2022-09-07
CL2021001868A1 (es) 2022-01-21
KR20210138134A (ko) 2021-11-18
IL284884B1 (en) 2025-05-01
PL3902800T3 (pl) 2022-12-27

Similar Documents

Publication Publication Date Title
MA55389A (fr) Complexe de gadolinium et d'un ligand chelateur derive de pcta diastereoisomeriquement enrichi et procede de preparation et de purification
MA55227A (fr) Complexe de gadolinium et d'un ligand chelateur derive de pcta diastereoisomeriquement enrichi et procede de synthese
FR3031800B1 (fr) Procede de determination du taux d'encrassement d'au moins un filtre d'un systeme de ventilation et systeme de ventilation associe
EP3684432C0 (en) Assembly and method for the preparation of a wound dressing
FR3049131B1 (fr) Procede de filtrage d'un signal d'entree numerique et filtre associe
EP3479758C0 (en) SYSTEM AND METHOD FOR BREATHING PATTERN EXTRACTION FROM PPG SIGNALS
EP4265183C0 (fr) Système automatisé de régulation de la glycémie d'un patient
EP3369713A4 (en) NITROGEN REMOVAL PROCESS, NITRIFICATION REACTION TREATMENT FOR WATER TREATMENT AND WATER TREATMENT PROCESS
EP3804504C0 (en) METHOD FOR IMPROVING THE ABSORPTION OF FERTILIZERS
EP3886957A4 (en) Diffuser for a component of a respiratory therapy system
MA53565A (fr) Procédés d'utilisation d'un composé phénoxypropylamine pour le traitement de la douleur
HK40119100A (en) Complex of gadolinium and a chelating ligand derived from a diastereoisomerically enriched pcta and preparation and purification process thereof
EP3878872A4 (en) Method for producing particulate water absorbent, and particulate water absorbent
HK40062157B (en) Complex of gadolinium and a chelating ligand derived of a diastereoisomerically enriched pcta and synthesis method
MA52430A (fr) Procédé de purification d'un solvant de nitrile
EP2029151A4 (en) PROCESS FOR PREPARING A DIALYZED EXTRACT OF BOCKSHORNKLEE SAMPLES
EP3368755A4 (en) Method and system for use when correcting supply of an additive to an exhaust gas stream
EP3908544C0 (de) Böschungsräumungssystem eines mischbettes und verfahren zum betreiben eines böschungsräumungssystems
MA52477A (fr) Procédé de commande d'un train dans un système de protection des trains, système de protection des trains
EP3834717C0 (de) Verfahren zu einem positionieren eines patienten
FR2990877B1 (fr) Systeme et procede de filtration d'un ecoulement d'eau
MA48929A (fr) Dispositif et procédé d'alignement d'éléments de noyau à l'aide d'un tel dispositif
TN2010000452A1 (fr) Procede pour la preparation de triamides a partir d'ammoniac et d'amidodichlorures